Secukinumab 2-Weekly vs 4-Weekly Dosing in Patients With Plaque-Type Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Secukinumab 2-Weekly vs. 4-Weekly Dosing in Patients With Plaque-Type Psoriasis: Results From the Randomized GAIN Study
Br J Dermatol 2020 Jul 11;[EPub Ahead of Print], K Reich, A Körber, U Mrowietz, M Sticherling, C Sieder, J Früh, T BachhuberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.